KinBio is a biopharmaceutical company headquartered in Rehovot, Israel, that specializes in the development and production of complex drugs and biosimilars. Their chemical synthesis of APIs is powered by their complex generics facility — the company can produce large quantities of highly delicate and complex APIs. KinBio offers end-to-end solutions for the development, characterization, and manufacturing of protein therapeutics specific to your needs, from concept to commercialization.